Wells Fargo
VNRX icon

Wells Fargo’s VolitionRx Ltd VNRX Stock Holding History

Wells Fargo’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24
Closed -$359 – 7502
2024
Q1 		$359 Buy
24
+1
+4% +$20 ﹤0.01% 6360
2023
Q4 		$332 Buy
23
+1
+5% +$15 ﹤0.01% 6477
2023
Q3 		$302 Buy
22
+6
+38% +$148 ﹤0.01% 6476
2023
Q2 		$436 Buy
16
+2
+14% +$66 ﹤0.01% 6519
2023
Q1 		$523 Buy
14
+1
+8% +$42 ﹤0.01% 6549
2022
Q4 		$654 Hold
13
– – ﹤0.01% 6314
2022
Q3 		$0 Buy
13
+1
+8% +$38 ﹤0.01% 7445
2022
Q2 		$1K Buy
12
+1
+9% +$50 ﹤0.01% 6627
2022
Q1 		$1K Hold
11
– – ﹤0.01% 6875
2021
Q4 		$1K Hold
11
– – ﹤0.01% 7087
2021
Q3 		$1K Sell
11
-1
-8% -$63 ﹤0.01% 6809
2021
Q2 		$1K Sell
12
-443
-97% -$30K ﹤0.01% 6751
2021
Q1 		$34K Sell
455
-243
-35% -$20.8K ﹤0.01% 5994
2020
Q4 		$54K Buy
698
+345
+98% +$23.8K ﹤0.01% 5564
2020
Q3 		$23K Sell
353
-252
-42% -$17.1K ﹤0.01% 5724
2020
Q2 		$47K Buy
605
+597
+7,463% +$43.1K ﹤0.01% 5507
2020
Q1 		$1K Buy
+8
New +$667 ﹤0.01% 6092

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's VNRX Position: Q2 2024 in Review

Wells Fargo sold out of VolitionRx Ltd (VNRX) in Q2 2024, closing a stake of 24 shares — an estimated $359 sold.

Wells Fargo first reported a position in VNRX in Q1 2020 and held it in 17 quarters. The position peaked at $54K in Q4 2020. 26 funds tracked by Wall St. Rank hold VNRX as of Q2 2024.

  • Wells Fargo reported no remaining VolitionRx Ltd position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 24 VolitionRx Ltd shares in Q2 2024, an estimated $359.
  • Wells Fargo first reported a position in VolitionRx Ltd in Q1 2020 and held it in 17 quarters.
  • Wells Fargo's VolitionRx Ltd position peaked at $54K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.